Anti-HIV-1 Activity of New Pyrrolyl Aryl Sulfones
J ournal of Medicinal Chemistry, 1996, Vol. 39, No. 2 529
(22) Scha¨fer, W.; Friebe, W.-G.; Leinhert, H.; Mertens, A.; Poll, T.;
Von der Saal, W.; Zilch, H.; Nuber, B.; Ziegler, M. L. Non-
Nucleoside Inhibitors of HIV-1 Reverse Transcriptase: Molec-
ular Modeling and X-Ray Structure Investigations. J . Med.
Chem. 1993, 36, 726-732.
(4) Baba, M.; Debyser, Z.; Shigeta, S.; De Clercq, E. Highly Potent
and Selective Inhibition of Human Immunodeficiency Virus Type
1 (HIV-1) by the HIV-1-Specific Reverse Transcriptase Inhibi-
tors. Drugs Future 1992, 17, 891-897.
(5) De Clercq, E. Antiviral Therapy for Human Immunodeficiency
Virus Infections. Clin. Microbiol. Rev. 1995, 8, 200-239.
(6) Pauwels, R. Discovery of TIBO, a New Family of HIV-1-Specific
Reverse Transcriptase Inhibitors. In The Search for Antiviral
Drugs; Adams, J ., Merluzzi, V. J ., Eds.; Birkha¨user: Boston,
1993; Chapter 4, pp 71-104.
(23) Chimirri, A.; Grasso, S.; Monforte, A.-M.; Monforte, P.; Zappala`,
M. Anti-HIV Agents. 1. Synthesis and in Vitro Anti-HIV
Evaluation of Novel 1H,3H-Thiazolo[3,4-a]benzimidazoles. Far-
maco 1991, 46, 817-823.
(24) Artico, M.; Silvestri, R.; Stefancich, G. Heterocycles with
a
(7) Koup, R. A.; Merluzzi, V. J .; Hargrave, K. D.; Adams, J .;
Grozinger, K.; Eckner, R. J .; Sullivan, J . L. Inhibition of Human
Immunodeficiency Virus Type 1 (HIV-1) Replication by the
Dipyridodiazepinone BI-RG-587. J . Infect. Dis. 1991, 163, 966-
970.
Benzothiadiazepine Moiety. 1. Synthesis of Pyrrolo[1,2-b]-s-
triazolo[3,4-d][1,2,5]benzothiadiazepine 9,9-Dioxide. Synth. Com-
mun. 1992, 22, 1433-1439.
(25) Stefancich, G.; Silvestri, R.; Pagnozzi, E.; Artico, M. Heterocycles
with a Benzothiadiazepine Moiety. 2. Synthesis of 2-Methyl-
1,3,4,14b-tetrahydro-2H-pyrazino[2,1-d]pyrrolo[1,2-b][1,2,5]-
benzothiadiazepine 10,10-Dioxide (Tiaaptazepine). J . Heterocycl.
Chem. 1994, 31, 867-869.
(8) Baba, M.; Shigeta, S.; Tanaka, H.; Miyasaka, T.; Ubasawa, M.;
Umezu, K.; Walker, R. T.; Pauwels, R.; De Clercq, E. Highly
Potent and Selective Inhibition of HIV-1 Replication by 6-Phen-
ylthiouracil Derivatives. Antiviral Res. 1992, 17, 245-264.
(9) Romero, D. L.; Morge, R. A.; Biles, C.; Berrios-Pena, N.; May,
P. D.; Palmer, J . R.; J ohnson, P. D.; Smith, H. W.; Busso, M.;
Tan, C.-T.; Voorman, R. L.; Reusser, F.; Althaus, I. W.; Downey,
K. M.; So, A. G.; Resnick, L.; Tarpley, W. G.; Aristoff, P. A.
Discovery, Synthesis, and Bioactivity of Bis(heteroaryl)piper-
azines. 1. A Novel Class of Non-Nucleoside HIV-1 Reverse
Transcriptase Inhibitors. J . Med. Chem. 1994, 37, 999-1014.
(10) Sahlberg, C.; Engelhardt, P.; J ohansson, N.-G.; Nore´en, R.;
O¨ berg, B.; Vrang, L.; Zhang, H. Synthesis and Anti-HIV-1
Activities of Resolved Cis-Cyclopropyl PETT Analogues, Belong-
ing to a New Series of Potent Non-Nucleoside HIV-1 Reverse
Transcriptase Inhibitors. XIIIth International Symposium on
Medicinal Chemistry, Paris, Sept. 19-23, 1994; Poster P209.
(11) Artico, M.; Massa, S.; Mai, A.; Marongiu, M. E.; Piras, G.;
Tramontano, E.; La Colla, P. 3,4-Dihydro-2-alkoxy-6-benzyl-4-
oxopyrimidines (DABOs): a New Class of Specific Inhibitors of
Human Immunodeficiency Virus Type 1. Antiviral Chem.
Chemother. 1993, 4, 361-368.
(12) Massa, S.; Mai, A.; Artico, M.; Sbardella, G.; Tramontano, E.;
Loi, A. G.; Scano, P.; La Colla, P. Synthesis and Antiviral Activity
of New 3,4-Dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DA-
BOs), Specific Inhibitors of Human Immunodeficiency Virus
Type 1. Antiviral Chem. Chemother. 1995, 6, 1-8.
(13) Mai, A.; Artico, M.; Sbardella, G.; Massa, S.; Loi, A. G.;
Tramontano, E.; Scano, P.; La Colla, P.; Synthesis and Anti-
HIV-1 Activity of Thio Analogues of Dihydroalkoxybenzyloxo-
pyrimidines. J . Med. Chem. 1995, 38, 3258-3263.
(14) Pauwels, R.; Andries, K.; Bebyser, Z.; Van Daele, P.; Schols, D.;
Stoffels, P.; De Vreese, K.; Woestenborghs, R.; Vandamme, A.-
M.; J anssen, C. G. M.; Anne, J .; Cauwenberg, G.; Desmyter, J .;
Heykants, J .; J anssen, M. A. C.; De Clercq, E.; J anssen, P. A. J .
Potent and Highly Selective Human Immunodeficiency Virus
Type 1 (HIV-1) Inhibition by a Series of R-Anilinophenylacet-
amide Derivatives Targeted at HIV-1 Reverse Transcriptase.
Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 1711-1715.
(15) Balzarini, J .; Pe´rez-Pe´rez, M.-J .; San-Fe´lix, A.; Valazquez, S.;
Camarasa, M. J .; De Clercq, E. [2′,5′-Bis-O-(tert-butyldimethyl-
silyl)]-3′-spiro-5′′-(4′′-amino-1′′,2′′-oxathiole-2′′,2′′-dioxide) (TSAO)
Derivatives of Purine and Pyrimidine Nucleosides as Potent and
Selective Inhibitors of Human Immunodeficiency Virus Type 1.
Antimicrob. Agents Chemother. 1992, 36, 1073-1080.
(16) Balzarini, J .; Camarasa, M.-J .; Karlsson, A. TSAO Derivatives:
Highly Specific Human Immunodeficiency Virus Type 1 (HIV-
1) Reverse Transcriptse Inhibitors. Drugs Future 1993, 18,
1043-1055.
(17) Bader, J . P.; McMahon, J . B.; Schultz, R. J .; Narayanan, V. L.;
Pierce, J . B.; Harrison, W. A.; Weislow, O. S.; Midelfort, C. F.;
Stinson, S. F.; Boyd, M. R. Oxathiin Carboxanilide, a Potent
Inhibitor of Human Immunodeficiency Virus Reproduction.
Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 6740-6744.
(26) Silvestri, R.; Artico, M.; Pagnozzi, E.; Stefancich, G. Heterocycles
with a Benzothiadiazepine Moiety. 3. Synthesis of Imidazo-
[5,1-d]pyrrolo[1,2-b][1,2,5]benzothiadiazepine 9,9-Dioxide. J .
Heterocycl. Chem. 1994, 31, 1033-1036.
(27) Silvestri, R.; Pagnozzi, E.; Stefancich, G.; Artico, M. Heterocycles
with
a Benzothiadiazepine Moiety. 4. Synthesis of Novel
Tetracyclic Rings by Intramolecular Cyclization of 10-Bromo-
acetyl-10,11-dihydro-11-ethoxycarbonylpyrrolo[1,2-b][1,2,5]-
benzothiadiazepine 5,5-Dioxide and its Derivatives. Synth.
Commun. 1994, 24, 2685-2695.
(28) Artico, M.; Stefancich, G.; Silvestri, R.; Massa, S.; Pagnozzi, E.;
Loi, A. G.; Musu, D.; Doa, M.; Scano, P.; La Colla, P. Pyrrolo-
benzothiazepines: a New Class of Non-Nucleoside HIV-1 Re-
verse Transcriptase Inhibitors. Med. Chem. Res. 1994, 4, 283-
290.
(29) Silvestri, R.; Pagnozzi, E.; Artico, M.; Stefancich, G.; Massa, S.;
La Colla, P. Synthesis of 9H-Pyrrolo[2,1-b][1,3,6]benzo-
thiadiazocin-10(11H)-one 4,4-Dioxide, a Potential anti-HIV-1
Agent. J . Heterocycl. Chem. 1995, 32, 683-685.
(30) Di Santo, R.; Costi, R., Artico, M.; Massa, S. Novel Heterocyclic
Systems. Synthesis of 10H-Pyrrolo[1,2-b][1,2,5]benzothiadiazocine
4,4-Dioxide and Related Derivatives. J . Heterocycl. Chem.,
submitted for publication.
(31) Artico, M.; Silvestri, R.; Pagnozzi, E.; Stefancich, G.; Massa, S.;
Loi, A. G.; Scano, P.; Corrias, S.; Spiga, M. G.; La Colla, P. 5H-
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): a Novel Class
of HIV-1-Specific Non-Nucleoside Reverse Transcriptase Inhibi-
tors. Unpublished results.
(32) Artico, M.; Silvestri, R.; Stefancich, G.; Massa, S.; Pagnozzi, E.;
Musu, D.; Scintu, F.; Pinna, E.; Tinti, E.; La Colla, P. Synthesis
of Pyrryl Aryl Sulfones Targeted at the HIV-1 Reverse Tran-
scriptase. Arch. Pharm. (Weinheim) 1995, 328, 223-229.
(33) McMahon, J . B.; Gulakowsky, R. J .; Weislow, O. S., Schultz, R.
J .; Narayanan, V. L.; Clanton, D. J .; Pedemonte, R.; Wassmundt,
F. W.; Buckheit, R. W., J r.; Decker, C. D.; White, L.; Bader, J .
P.; Boyd, M. R. Diarylsulfones, a New Chemical Class of Non-
Nucleoside Antiviral Inhibitors of Human Immunodeficiency
Virus Type
1 Reverse Transcriptase. Antimicrob. Agents
Chemother. 1993, 37, 754-760.
(34) Williams, T. M.; Ciccarone, T. M.; MacTough, S. C.; Rooney, C.
S.; Balani, S. K.; Condra, J . H.; Emini, E. A.; Goldman, M. E.;
Greenlee, W. J .; Kauffman, L. R.; O’Brien, J . A.; Sardana, V.
V.; Schleif, W. A.; Theoharides, A. D.; Anderson, P. S.
5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: A Novel, Non-
Nucleoside Inhibitor of HIV-1 Reverse Transcriptase. J . Med.
Chem. 1993, 36, 1291-1294.
(35) Young, S. D.; Amblard, M. C.; Britcher, S. F.; Grey, V. E.; Tran,
L. O.; Lumma, W. C.; Huff, J . R.; Schleif, W. A.; Emini, E. E.;
O’Brien, J . A.; Pettibone, D. J . 2-Heterocyclic Indole-3-sulfones
as Inhibitors of HIV-1 Reverse Transcriptase. Bioorg. Med.
Chem. Lett. 1995, 5, 491-496.
(36) Chimenti, F.; Vomero, S.; Nacci, V.; Scalzo, M.; Giuliano, R.;
Artico, M. Research on Compounds with Antiblastic Activity.
LVII-Anthramycin and Related Compounds. VI-Synthesis of
Pyrrolo[1,2-b][1,2,5]benzothiadiazepine and Related Derivatives.
Farmaco, Ed. Sci. 1974, 8, 589-597.
(18) Kleim, J .-P.; Bendre, R.; Billhardt, U.-M.; Meichsner, C.; Riess,
G.; Ro¨sner, M.; Winkler, I.; Paessens, A. Activity of a Novel
Quinoxaline Derivative against Human Immunodeficiency Virus
Type 1 Reverse Transcriptase and Viral Replication. Anti-
microb. Agents Chemother. 1993, 37, 1659-1664.
(19) Derrett, N. K.; Bojanic, D.; Merson, J . R.; Stephenson, P. T.
(37) Topliss, J . G.; Sherlock, M. H.; Reimann, H.; Konzelman, L. M.;
Shapiro, E. P.; Pettersen, B. W.; Schneider, H.; Sperber, N.
Antihypertensive Agents. I. Non-diuretic 2H-1,2,4-benzothia-
diazine 1,1-dioxide. J . Med. Chem. 1963, 6, 122-127.
(38) (a) Clauson-Kaas, N.; Tyle, Z. Preparation of Cis- and Trans-
2,5-Dimethoxy-2-(acetamidomethyl)-2,5-dihydrofuran, of Cis-
and Trans-Dimethoxy-2-(acetamidomethyl)tetrahydrofuran, and
1-Phenyl-2-(acetamidomethyl)pyrrole. Acta Chem. Scand. 1952,
6, 667-670. (b) Elming, N.; Clauson-Kaas, N. The Preparation
of Pyrroles from Furans. Acta Chem. Scand. 1952, 6, 867-874.
(39) Wagner, A. W.; Banholzer, R. 1-Substituirte 5-nitro-1H-1.3.2-
benzodithiazol-3.3-dioxyde. (1-Substituted 5-Nitro-1H-1,3,2-ben-
zodithiazole 3,3-Dioxide.) Chem. Ber. 1963, 96, 1177-1186.
Imidazo[2′,3′:6,5]dipyrido[3,2-b:2′,3′-e]-1,4-diazepines:
Non-
Nucleoside HIV-1 Reverse Transcriptase Inhibitors with Greater
Enzyme Affinity than Nevirapine. Bioorg. Med. Chem. Lett.
1992, 2, 1745-1750.
(20) De Lucca, G. V.; Otto, M. J . Synthesis and Anti-HIV-1 Activity
of Pyrrolo[1,2-d](1,4)benzodiazepin-6-ones. Bioorg. Med. Chem.
Lett. 1992, 2, 1639-1644.
(21) Buckheit, R. W., J r.; Hollingshead, M. G.; Germany-Decker, J .;
White, E. L.; McMahon, J . B.; Allen, L. B.; Ross, L. J .; Decker,
W. D.; Westbrook, L.; Shannon, W. M.; Weislow, O.; Badre, J .
P.; Boyd, M. R. Thiazolobenzimidazole: Biological and Biochemi-
cal Anti-Retroviral Activity of a New Non-Nucleoside Reverse
Transcriptase Inhibitor. Antiviral Res. 1933, 21, 247-265.